Literature DB >> 33828745

Vergence Eye Movements: From Basic Science to Clinical Application - Foreword to the Special Issue.

Wolfgang Jaschinski1, Rudolf Groner2.   

Abstract

The abstract book of the last European Conference on Eye Movements [1] lists abstracts of 373 presentations, but less than five percent investigate vergence eye movements, i.e. the coordination of the right and left eye. Why then a special issue on this neglected issue? Human vision under natural conditions involves both eyes in coordination controlled by interacting processes subsumed under the concept of vergence.. Further, vergence is important for people in their daily lives since disorders of vergence can have serious consequences: ophthalmologists deal with squinting patients on the basis of heterophoria and heterotropia testing, eye strain or visual complaints can be related to impaired vergence dynamic or less accurate static vergence, remediation by optometrist includes vergence training or prism eye glasses, etc.

Entities:  

Keywords:  NPC; Vergence; binocular fusion; disparity; eye movements; heterophoria; vergent eye movements

Year:  2020        PMID: 33828745      PMCID: PMC7881834          DOI: 10.16910/jemr.12.4.0

Source DB:  PubMed          Journal:  J Eye Mov Res        ISSN: 1995-8692            Impact factor:   0.957


  3 in total

1.  Dynamics of the Disparity Vergence Fusion Sustain Component.

Authors:  John L Semmlow; Chang Yaramothu; Tara L Alvarez
Journal:  J Eye Mov Res       Date:  2019-12-04       Impact factor: 0.957

2.  Changes in the Disparity Vergence Main Sequence after Treatment of Symptomatic Convergence Insufficiency in Children.

Authors:  Mitchell Scheiman; Chang Yaramothu; Tara L Alvarez
Journal:  J Eye Mov Res       Date:  2019-12-04       Impact factor: 0.957

3.  Target Eccentricity and Form Influences Disparity Vergence Eye Movements Responses: A Temporal and Dynamic Analysis.

Authors:  Chang Yaramothu; Rajbir S Jaswal; Tara L Alvarez
Journal:  J Eye Mov Res       Date:  2019-12-09       Impact factor: 0.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.